Co-Diagnostics, Inc. (CODX)
NASDAQ · Manufacturing · Surgical & medical instruments & apparatus
$1.09−$0.0600 (−5.22%) on the dayAs of the close; data may be delayed.
CODX price, last 12 months
Key stats
- Previous close
- $1.15
- Open
- $1.15
- Day range
- $1.09 – $1.16
- 52-week range
- $0.9057 – $46.50
- Volume
- 189.8K
- Avg volume (20 days)
- 256.8K
- Market cap
- $7.6M
Performance
1W+15.3%
1M−12.8%
3M−64.4%
6M−46.0%
YTD−78.5%
1Y−91.2%
vs S&P 500, 1Y−108.0 pts
Technicals and fundamentals
About Co-Diagnostics, Inc.
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
- Sector
- Manufacturing
- Industry
- Surgical & medical instruments & apparatus
- Listed on
- NASDAQ
- Market cap
- $7.6M